Aemetis (NASDAQ:AMTX) Announces Earnings Results

Aemetis (NASDAQ:AMTX) issued its earnings results on Tuesday. The specialty chemicals company reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.09, Zacks reports. The business had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the previous year, the firm posted ($0.59) EPS.

Aemetis Price Performance

AMTX traded down $0.06 during trading on Thursday, reaching $4.07. The company had a trading volume of 848,065 shares, compared to its average volume of 807,098. The company has a market cap of $192.09 million, a P/E ratio of -1.80 and a beta of 1.23. Aemetis has a 12 month low of $2.10 and a 12 month high of $7.03. The business’s fifty day moving average price is $2.77 and its 200 day moving average price is $3.06.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on AMTX shares. Truist Financial reiterated a “hold” rating and issued a $3.50 price objective (down previously from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. Ascendiant Capital Markets lowered their price target on Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. UBS Group reduced their price objective on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research note on Monday, August 19th. HC Wainwright reaffirmed a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research note on Friday, August 2nd. Finally, StockNews.com raised shares of Aemetis to a “sell” rating in a research report on Wednesday, July 31st. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $12.95.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.